Embed Size (px)
Citation preview
MODULE 5
PART 2: Introduction to Pharmaceutical and Health Product Management (PHPM) - Country Profile Approach
GLOBAL FUND GRANT CONSOLIDATION WORKSHOP
DATE
OVERVIEW
Background Key Features: Country Profile Approach Key Components of Proposed Country Profiles PHPM Country Profile Approach Procurement Planning in the PHPM country profile
approach Potential Benefits : PHPM Country Profile approach
Key Messages
2
BACKGROUND
Traditionally, the Global Fund requires a standard set of documents for each Grant to be signed Performance Framework PSM Plan Detailed Workplan and Budget
The proposed Country Profile Approach moves to a model where a standard set of information on PHPM systems is available for each country: “The Country Profile” Holistic Review of systems used for program
implementation Done once Updated at regular intervals Comprehensive and available as a public document 3
Based on indicators esp. those of country health systems
Provides a more holistic view of the systems used for program implementation through a country program-focused assessment
Aims to avoid submission of repetitive information in the form of PSM Plans for each new grant.
Provides a standard set of information on policies, systems and structures of a country’s Pharmaceutical Sector.
Country Profile has 3 parts:1. Context and systems description2. Operational Systems3. Action plan based on 1&2
4
KEY FEATURES: COUNTRY PROFILE APPROACH
SCENARIO FOR COUNTRY X WITH MULTIPLE GRANTS AND PHPM COUNTRY PROFILE
PSM Plan HIV R7
PSM Plan HIV R6
PSM Plan HIV R3
PSM PlanTB R6
PSM PlanTB R4
PSM Plan Mal R8
PSM Plan Mal R5
PSM Plan Mal R3
Country Profile
KEY COMPONENTS: PROPOSED COUNTRY PROFILE
Narrative section of traditional PSM Plan replaced by focused
questions on:
1. Context and Systems Description
2. Operational systems in place
6
PART 1 AND 11: PHPM COUNTRY PROFILE 7
PART 3:ACTION PLAN – COUNTRY PROFILE MONITORING PLAN
8
ACTION PLAN – COUNTRY PROFILE MONITORING PLAN
STRENGTHS WEAKNESSES
Section1 : Pharmaceutical and health products policies, laws, regulations and standards
Section2 : Pharmaceutical Quality Assurance System
ACTION PLAN
Detailed Description of the Strengthening Measure
Responsibility TimelineTotal Funding*
(Specify amount)
Funding Source(s) (Specify funding organization and
amount)
Technical Assistance (Specify type of TA and
amount, if needed)
PROCUREMENT PLAN The “Procurement Plan” is disease specific Includes:
List of health products to be procured with Grant resources, including quantities and unit costs;
Forecasting methodology; Procurement schedule; Compliance with the Global Fund’s QA Policy.
NB:The narrative Sections of the PSM Plan have
been removed as a requirement - simplified
9
PROCUREMENT PLANTable of contents: Table 1: Procurement and Pharmaceutical Management
Cost Summary Table 2: Selection in compliance with standards Table 3: Compliance with the Global Fund’s Quality
Assurance Policy Table 4: List of pharmaceutical products, estimated
quantities and cost Table 5: List of non-pharmaceutical products,
estimated quantities and cost Table 6: Procurement schedules Table 7: Overview of funding for antiretroviral, anti-
malarial and anti-TB medicines and health products
10
EXAMPLE - PROCUREMENT PLAN R2 RCC11
Table 4 List of pharmaceutical products, estimated quantities, and cost
Product / Dosage Form Strength
Unit of measure
ment (Tab, ml,
pack)
Estimated Unit cost
(incoterms)
Year 1 Year 2 Year 3 (if applicable)Procurement conducted
by
Procurement
methodQuantit
yTotal Cost
QuantityTotal Cost
QuantityTotal Cost
Antiretroviral medicines
Lamivudine 150mg One oral solid
0.03 25070 469,610 539,710
Abacavir 300mg One oral solid
0.24 44,060 230,130 278,060
Nevirapine 200mg
One oral solid
0.04 0 70,500 77,800
Lopinavir/ritonavir200/50mg
One oral solid
0.24 79,140 171,660 214,220
Antimalarial medicines
Antituberculosis medicines
Other medicines
Total Cost per year
EXAMPLE - PROCUREMENT PLAN SSF
12
Table 4 List of pharmaceutical products, estimated quantities, and cost
Product / Dosage Form Strength
Unit of measure
ment (Tab, ml,
pack)
Estimated Unit cost
(incoterms)
Year 1 Year 2 Year 3 (if applicable)Procurement conducted
by
Procurement
methodQuantit
yTotal Cost
QuantityTotal Cost
QuantityTotal Cost
Antiretroviral medicines
Lamivudine 150mg One oral solid
0.03 469,610 539,710 494,800
Abacavir 300mg One oral solid
0.24 230,130 278.060 202,850
Nevirapine 200mg
One oral solid
0.04 70,500 77,800 77,800
Lopinavir/ritonavir200/50mg
One oral solid
0.24 171.660 214,220 94,700
Antimalarial medicines
Antituberculosis medicines
Other medicines
Total Cost per year
PROCUREMENT PLAN
Table 4: List of pharmaceutical products, estimated quantities and cost
Takes into consideration Quantities on hand Number of patients on treatment Emergency procurements made prior to SSF signing Period of overlap
13
14
PROPOSED PROCUREMENT PLAN APPROVAL PROCESS WITH COUNTRY PROFILE
Country Profile +
LFA PHPM Assessment
LFA Assessment: Procurement plan
Procurement plan
Prior to grant negotiations During grant negotiations
Procure-ment plan Approval
CONSOLIDATING PROCUREMENT PLAN UNDER THE PHPM COUNTRY PROFILE
When a PHPM country profile is available
Consolidate procurement plans per disease per PR
Reflect detailed list of health products to be procured under the consolidated grant
15
COMPARISON OF THE TWO APPROACHES
PSM PLAN
1. PR system
2. Describes PR’s institutional capacity for PSM
3. Elements of PSM cycle
COUNTRY PROFILE
1. Country systems
2. Context and Systems Description
3. Operational systems in place
16
17WHAT ARE THE POTENTIAL BENEFITS OF THE
COUNTRY PROFILE APPROACH?
PARTICIPANT TEAZER !
18
Reinforce focus on National Systems vs. required documents
Assist countries to plan how grant resources can help to strengthen systems Use information in the Country Profiles to assist PRs to identify
capacity building needs Provides avenue to engage national stakeholders on health and
pharmaceutical PSM issues
Improve TGF knowledge of the systems used for program implementation
Streamline and speed-up the grant signing process by de-linking the LFA PHPM Assessment and the grant signing
Others?
POTENTIAL BENEFITS OF THE COUNTRY PROFILE APPROACH
REQUIREMENTS FOR GRANT SIGNATURE WITH A PHPM COUNTRY PROFILE
1. Assessed Country Profile (not older than 12 months)
2. Update on the sections of the existing PHPM country profile that may have changed
3. Revised procurement plan for the disease component
4. Desk review by the LFA of the revised Procurement Plan and of any sections of the Country Profile that have changed
5. A scheduled LFA Assessment not linked to grant negotiations
19
KEY MESSAGES
Use of the PHPM Country Profile is replacing the PSM Plan
in future grants
For GC, implementation arrangements in consolidated PSM/ Procurement Plan should be harmonized with individual PSM/ Procurement plans or have plans to manage transition
In consolidated grants, lists of health products and quantities (Annexes 1a&b) should be aligned to consolidated PF targets, work plan and budget
20
FOR MORE INFORMATION
Contact Global Fund Pharmaceutical Management
Advisory Services TeamEmail: [email protected]
UNAIDS Technical Support Facility EA & SA WHO EPM
21
ACKNOWLEDGEMENTS
Grant Management Solutions
The Global Fund Secretariat
UNAIDS Technical Support Facility
The AIDS Alliance
AIDSPAN
22
DISTRIBUTE EXAMPLE OF PHPM COUNTRY PROFILE IF AVAILABLE
OR
PROVIDE DETAILS OF A LINK TO A PHPM COUNTRY PROFILE
23
